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ABSTRACTS 
Abstracts of Original Contributions: Young Investigators 
Awards Competition 
The purpose of the Awards is to find and encourage 
the Young Investigators of promise on whom the 
future of cardiology depends. Any physician/scientist 
who is currently in a residency or fellowship training 
program or who has been in such a program within 
the past three years is eligible to submit an original 
Investigation. Medical students and Ph.D. candidates 
are also eligible for the competition. 
The Judging Committee will select a first and sec- 
ond place winner and three honorable mentions for 
each of the following categories: a) Clinical Investiga- 
tions; b) Physiology, Pharmacology and Pathology; and 
e) Molecular and Cellular Cardiology. The Awards will 
be presented at the 45tb Annual Convocation Cere- 
mony on Wednesday, March 27, at 6:00 p.m. The 
Young Investigator of the Year (first place) for each 
category will receive a plaque, a certificate and $2,000. 
Second place winners each receive a certificate and 
a check for $1,000. The three honorable mentions 
each receive a certificate and a check for $500. The 
American College of Cardiology Young Investigators 
Awards Competition is supported by grants from 
Searle and Boehringer Mannheim Pharmaceuticals 
Corporation. 
Timothy J. Gardner, ]MID, FACC 
Chair 
1996 Young Investigators Awards Committee 
Awards Competition- Young I nvest igators  
Phys io logy ,  Pharmaco logy ,  and  Patho logy  
Monday, March 25, 1996,10:30 a .m. -Noon 
Orange County Convention Center, Room 231 
10:30 
~ Accelerated Re-Endothellalization and Reduced 
Nasintimal Thickening Following Catheter Transfer 
of phVEGFlss 
Takayuki Asahara, Donghui Chen, Marianne Keamey, Susan Rossow, 
Jonathan Passed, James R Symes, Jeffrey M. Isner. St. Elizabeth's Medical 
Center, Boston, MA; Tufts University School of Medicine, Boston, MA 
W¢ investigated the hypothesis that an endothelial ce~J (EC) mitogen could 
sere as the basis for a novel gane therapy strate~* designed to facilitate 
reendothelialization (rET), reduce nsointmal thickening, and promote recov- 
ery of EG dysfunction following balloon injury. New Zealand white rabbits 
underwent simultaneous balloon injury and gene transfer of one femoral 
artery with phVEGF~ss, encoding the 165-amino add Isolorm of vascular 
endothelial growth factor (VEGF); or LacZ. In each animal transfected with 
phVEGFlcs or LacZ, the oontralatorel femoral artery was also subjected to 
balloon injury, but not gane transfer. 
For lacZ, rET remained inoomplete at 4 wks post-transfection; i  contrast, 
phVEQFles produced prompt rE'r which was 95% complete by 1 wk. More- 
over, rET in the contralateral, balloon-injured, non-transfected limb of the 
VEGF group was similarly accelerated. Intimal thickening (intima to media 
area ratio) was oorrespondlngly reduced (0.14 vs 0.69), as was the frequency 
of thrombotio cclusion (3.1% vs 21.9%), and the vasomotor esponse to 
EC-dependent egoniats was preserved as normal in VEGF transfestants vs 
controls. A similar benefit was observed for the contralateral, balloon-injured, 
non.trensfected limb. 
Thesa expedmantal findings thus establish proof of prindple for the concept 
that cathater-mediated, mitogen-accelereted rET can be aohieved by arterial 
gene transfer, with a consequent inhibition el neointimel thickening, reduction 
in thrombogenicity, and restoration of endotheliurn<Jepondent vasomotor 
reactivity. 
10:45 
~ T h e  Doppler Effect as a Cause for Irregular 
Electrocardiograms in Rsentrant Ventricular 
An 'h~m~ 
Richard A. Grey, Jos6 Jelife, William T. BO~ter, Cendido Cabs, Jorge 
M. Davidanko, Arkedy Pertsov. SUNY Health Science Center at Syracuse, 
Syracuse, NY 
ReenVant excitation of the myocardium is thought o be the underlying 
mechanism for the most da~garous cardiac an'hythmies including venVicular 
tachycardia nd ventdcular fibrillation. The relationship between the spatio- 
temporal patterns of electrical as'dvify in the heart and the clinically useful 
elec~osardiograms remain unclear. To study this rela~oeship we utilized a 
combination of high-resolulJon video imaging, numerical sirnula'dons, elec- 
trocardiogrephy and image processing. We recorded the patterns of wave 
propagation on the surface of the isolated langendodf-perfused mbbif heart 
dudng vantricutar arrbythmies in which a single mentrent source was ob- 
served, i'o cemplement these studies we podonned computer simutet]ons of 
reentrant waves in a realistic three-dimensional head geomelry. Our results 
indicate that the speed of the reentrant source was related to the irregularity 
of the eleclrocard]ogram through the Doppler mechanism. If the dimension- 
less ratio of the speed of the reenVant source divided by the wave speed was 
small (less than 5%) the electmcardiogrem was monomoq)hlc, if this ratio was 
inten'nediate (5 to 30%) the electrocardiographic pagem was polymorphic, 
and if this radio was large (greater than 30%) the electmcan~ogrems were 
indistinguishable from fibrillation. Quantitative comparisons using Doppler 
equations were sucoessful in predi~ng the width of the frequency spectra of 
elentmcan~ograms (a measure of irregularity) and the ratio of pedods ahead 
and behind the moving mentrant source. The Doppler phenomenon previdas 
a robust mechanis~o explanation for the irregulanty of electrogremS recorded 
dudng reentrant anhythmias. 
11:00 
J 407-3 J Mathematics of Systol ic Pulmonary Vein Flow: a 
Closed Form Analytical Solution Incorpor,~ng 
Fundamental Principles and Key Variables 
Randall Y. Grimes, Ajit P. Yoganathan, Robert A. Levine. Georgia Institute of 
TechnoI,Jgy, Atlant~ GA 
Systolic pulmonary venous (PV) flow is becoming part of the non-invasive as- 
sessment of left atrial function and ixessure. However no unifying model of the 
determinants of systOlic PV flow exists. A rna~ematkcel model of atrium and 
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PV tree was developed where pressure was modeled as the product of chain- 
bar elastanca and volume. An analytical solution of the unsteady Bernoulli 
equation was achieved by lineadzing the equation. The solution equation 
consisted of a cosine function, which captures visa largo, and a sine function, 
which captures vis a fmnte. Time-varying systolic PV velocity, ut(t) -cms, is 
a function of the following variables: total atrial suction created by atrial re- 
laxation (z~Paf -- mmHg) and mitral annular descent (&Pm¢ - mmHg), atrial 
(Ea - mmH~rco) and PV alastance (Epv), net atrial-- PV elactance (Enet = Ea 
+ Ew), the average rate of PV tree replenishment from the capillaries (QL -- 
cm31s), total PV cross*sectional rea at the atrial junction (A-  cm2), and PV 
inertanca (pLea -- g/cm2). This model found that tl'e peak velocity and inte- 
gral of systolic PV flow increased as atrial suction and PV tree replenishment 
increased, but decreased as atrial and PV elastanca, PV inedanca, and PV 
crsss-sectional area increased. Also, this model predicts aspects of systolic 
PV flow that are consistent with expedmental and clinical observations: (i) 
the vis a tergo component of systolic PV flow is minimized by compliant PVs 
(small PV elastanca); (if) atrial events, so-called visa fronte, dominate the 
magnitude of systolic PV flow; (iii) systolic PV flow is reduced by elevations in 
atrial pressure but onlywhan compliance is also reduced; (iv) compensatory 
increases in atrial suction and PV tree replenishment may overcome reduc- 
tions in systolic PV flow due to elevated atdal pressures; (v) PV inertanca nd 
area are important dP.terminants of the magnitude and timing of PV flow. 
U( t )=~ 1-cos  (t) + ~ sin (t) 
11:15 
~ Differential Sympathetic of  Muscle Neural Control  
Oxygenat ion in Resting and Exercising Human 
Skeletal Muscle 
Jim Hansen, Gall D. Thomas, William J. Parsons, Ronald G. Victor. UT 
Southwestern, Dallas, Texas 
Although the muscle metaboreflex triggers increases in muscle sympathetic 
nerve activity (SNA) targeted to beth resting and exercising human skeletal 
muscle, our recent rat studies advance the hypothesis that the vasocon- 
striction normally evoked by increased muscle SNA is salectively attenuated 
in the contracting muscle, thereby optimizing muscle perfusion. The abil- 
ity to continuously measure muscle oxygenation (cytochrome a,a3 redox 
state and tissue oxygen stores (t(HbO~ + MbO~)) in exercising muscle with 
near infrared spectroscopy while simultaneously measudng muscle SNA 
(micronecrography) provided a new opportunity tO test this hypothesis in 
humans. Specitically, we asked if a reflex increaSe in muscle SNA decreases 
muscle oxygenation i  resting, but not in exercising muscle. In 10 healthy hu- 
mans, we measured oxygenation in forearm muscle during reflex increases 
in muscle SNA evoked by non-hypotenslve tower body negative pressure 
(LBNP, -20 mmHg) at rest and dudng mild rhythmic handgdp (5 rain 20% of 
maximum). At re~', LBNP increased muscle SNA by 292 4. 72% (mean -*- SE) 
and decreased t(HbO2 + MbO2) by 10 4. 1% (p < 0.05) of the maximal de- 
crease (assessed with complete forearm ischemia). This decrease in t(HbO 
2 + MbO2) in the resting forearm was sympathetically-mediated because 
it was abolished by local sympathetic block with bretylium. Handgdp alone 
caused no change in muscle SNA, but rapidly decreased t(HbO2 + MbO2) 
to a steady state 28 4- 4% below baseline. Importantly, when superimposed 
on handgdp, LBNP increased MSNA by 305 4. 59%, but now had no effect 
on tissue oxygenation in the exercising muscle (zit(HbO.a ÷ MbO2) = +0.4 
4- 3%, p = ns). These data provide direct evidence in humans that reflex 
sympathetic activation decreases oxygenation in resting, but not in exercis- 
ing human skeletal muscle. This mechanism would optimize oxygenation of 
active muscle when the muscle metaboreflex iS engaged. 
11:30 
~ T h e  Pharmace-Genctice of  Congenital  Cardiac 
Defects in Retinoic Acid Receptor Oeflelent Mouse 
Embryos 
Henry M. Sucov, Vicky LaMorte, Jiangming Luo, Vincent Giguere, Ronald 
M. Evans. Univ. of Southern California SchooI of Medicine, Los Angeles, CA 
Germline mutations in several of the genes which encode receptors for the 
signaling molecule retinoic acid (PA) have been previously established in 
mica. Cardiac phenotypes which emerge in mutant embryos include defects 
in the ventricular chamber, conus, truncos, and aortic arch artedes. Based 
on new experimental and theoretical observations, the following conclusions 
have been drawn concerning the pharmacology of RA receptor function in 
mediating complex aspects of cardiac morphogenasis: (1) the level of func- 
tional receptor, known to be a heterodimsr of RAR and RXR monomers, is 
dictated by equilibrium considerations; (2) in the tissue involved in septation 
of the tmncus, the levels of RAR and RXR monomers are roughly compa- 
r'abte, explaining the emergence of persistent truncus artedosus only after 
combined mutation of PAR and RXR; (3) target genes of RA action critical in 
the morphogansSiS of the ventricular chamber contain receptor binding sites 
in their promoters of moderate, rather than high, affinity; this is also likely 
to be true in most other cases of RA action; (4) differentiation of the conus 
cushions is a significantly different response to RA than is morphoganesis of 
either the truncus or the vantricutar chamber, in that the conus is sensitive to 
beth insufficient or excess RA, whereas the tmncus and ventdcular chamber 
are sensitive to only RA deficiency; (5) the pharmacology of the RA recep- 
tors may in some cases make it possible to reverse the consequences of 
receptor mutation by treatment with exogenous RA; this approach was not 
successful in rescuing the hypoplastic ventricular phenotype, indicating that 
receptor mutation also supresses the inducible RA response to below the re- 
quired threshold in this tissue. These conclusions make testable predictions 
concerning the molecular mechanisms of normal and pathological cardiac 
morphoganesis, which will be evaluated through future molecular analysis. 
Discussion 11:45 
•• Young Invest igators  Awards  Compet i t ion -  
Molecular and Ce l lu la r  Card io logy  
Monday,  March 25, 1996, 2 :00  p .m. -3 :30 p.m. 
Orange County Convent ion  Center,  Room 231 
2:00 
I -4-~- '~ Localization of  the Gene for  Familial Id iopathic 
Dilated Card iomyopathy to Chromosome lq32  
Jean-Bernard Durand, Linda L. Bechinsld, Lisa Bailing, Grazyna 
Z. Czemuszewicz, Antoine B. Abchee, Qun Tec Yu, Rite Hill, Jonah Ifegwu, 
A.J. Marian, Ramon Brugada, Staven Daiger, Jane M. Gregoritch, 
Jeff Anderson, Miguel Quifiones, Jeffrey A. Towbin, Robert Roberts. Baylcr 
College of MedicirTe, I~ousten, Texas 
Cardiac failure is the tastast growing cardiovascular condition in the Western 
wodd with over 400,000 new cases per year in the U.S. The cost in the U.S. 
for cardiac transplantation alone is over $200 million and for all cardiac failure 
over $10 billion. Dilated cardiomyopathy (DCM), the most common cause 
of heart failure, is a pdmary cardiac disease charactedzed by vantricular di- 
latation and impaired systolic contraction and manifested clinically by either 
sudden death or pump failure. The cause for DCM is unknown (idiopathic, 
IDCM) with 20% estimated to be inherited. To identify the genetic defect for 
IDCM one must first map the chromosomal ocus. Thus, we studied a four 
generation kindred with ten members having IDCM, detected by echecardiog- 
raphy. IDCM segregated as a highly panetrant autosomal dominant disorder. 
A genome search was performed using short tandem repeat pofymorphic 
(STRP) markers. Two-point and multi-point linkage analysis was conducted 
assuming ponetranca to be 00%. Approximately 90% of the genome was ex- 
cluded by multi.point analysis of > 400 mad~ers. Peak led score of 5.78 was 
obtained at the marker DIS414 with t) = 0% recombination. Peak multi-point 
Iod score, also at D1S414, was 6.37. Haplotype analysis identified recombi- 
nation events between the disease gane and polymoq0hic markers in seven 
individuals. The region of lq common to all ten affected individuals is flanked 
by markers D1S249 and D1 $549 which are approximately 20 cM apart. Rea- 
sonable candidates including myosin-binding protein-H, MEF-2D, renin and 
plasma membrane calcium transporting ATPase, are known to be localized 
to this region and studies are now underway using the positional candidate 
approach to isolate and identify the responsible gane. Identification of the ge- 
netic defect should elucidate the molecular basis for familial DCM, providing 
a means for precise diagnosis and screening of asymptomaflc individuals at 
risk pdor to the development of this disease, which is a necessary step in our 
ultimate goal of providing effective prevention and treatment of this disease. 
2:15 
~ A  Functional Role fo r  Endothelin-1 in 
Norepinephrine- lnduced Ventricular Hypert rophy in 
Vivo and in Vitro 
Samer Kaddoura. MRCP, National Heart & Lung Institute, London, United 
Kingdom 
Background Endothelin-1 (ET-1) has potent effects upon call growth. We 
tested the hypothesis that endogenous ET-I plays a functional role in nore- 
pinaphfine (NE)-induced ventdcular hypertrophy by studying physical indices 
